ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MD vs NHC // REVENUE GROWTH (YOY)

Pediatrix Medical Group Inc. (NYSE) VS. National HealthCare Corporation (NYSE) • 15-METRIC TALLY: MD 5 — NHC 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MD VS. NHC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MD NHC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 33.60% 10.10% +23.50 MD /roic <GO>
EV/EBITDA & P/E Valuation 9.6x 20.5x -10.90 MD /valuation <GO>
Free Cash Flow Yield 11.43% 4.47% +6.96 MD /fcf-yield <GO>
Operating Margin — 8.50% — TIE /operating-margins <GO>
Net Profit Margin — 7.90% — TIE /net-margins <GO>
Revenue Growth (YoY) ACTIVE — 16.10% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 1.16% -1.16 NHC /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 6.61 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 8/9 -2.00 NHC /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 71.7 35.1 +36.57 MD /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 13.3x 23.3x -10.00 MD /forward-pe <GO>
Enterprise Scale & Market Cap $2.37B $3.32B -$951.8M NHC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MD REV NHC REV MD GROSS % NHC GROSS % MD FCF NHC FCF
FY 2025 $0 $1.52B — — $271.1M $148.6M
FY 2024 $0 $1.31B — — $206.6M $79.7M
FY 2023 $0 $1.14B — — $137.3M $111.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MD // BETA —
NHC // BETA —